Jingshan Tong (J Tong)

Years Active: 2016-2023
Publications (10 Years): 5

Jilin University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Jilin University Sep 01 2008 - Jul 01 2011

China

PHD

Changchun University of Science and Technology Sep 01 2005 - Jul 01 2008

China

MSC

Publications

Kyle Knickelbein, Jingshan Tong, Dongshi Chen, Yi-Jun Wang, Sandra Misale, Alberto Bardelli, Jian Yu, Lin Zhang
Correction: Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer. Oncogene (2023)
Jingshan Tong, Xiao Tan, Denise Risnik, Man Gao, Xiangping Song, Kaylee Ermine, Liangfang Shen, Shaomeng Wang, Jian Yu, Lin Zhang
BET protein degradation triggers DR5-mediated immunogenic cell death to suppress colorectal cancer and potentiate immune checkpoint blockade. Oncogene 40 (48) (2021)
Rochelle Fletcher, Jingshan Tong, Denise Risnik, Brian J Leibowitz, Yi-Jun Wang, Fernando Concha-Benavente, Jonathan M DeLiberty, Donna B Stolz, Reet K Pai, Robert L Ferris, Robert E Schoen, Jian Yu, Lin Zhang
Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis. Oncogene 40 (11) (2021)
Kyle Knickelbein, Jingshan Tong, Dongshi Chen, Yi-Jun Wang, Sandra Misale, Alberto Bardelli, Jian Yu, Lin Zhang
Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer. Oncogene 37 (33) (2018)
Jingshan Tong, S Tan, F Zou, J Yu, L Zhang
FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation. Oncogene 36 (6) (2016)

Jingshan Tong.css-eqlu8i{font-size:small;padding-left:4px;} (J Tong)